Evotec SE (EVO) Net Margin Growth (1y) (2010 - 2025)

Evotec SE (EVO) Net Margin Growth (1y) (2010 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 364.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -82.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -4,395.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -538.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 9,850.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2,292.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -146.00
10 Evotec SE 351.60 Mn 351.08 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 4.77 Mn
Sep 30, 2025 313.00
Dec 31, 2024 -7.41 Mn
Sep 30, 2024 -4,912.00
Dec 31, 2023 2.00 Mn
Sep 30, 2023 -734.00
Jun 30, 2023 1,025.00
Dec 31, 2022 -8.44 Mn
Sep 30, 2022 -5,691.00
Jun 30, 2022 -5,964.00
Mar 31, 2022 -8,408.00
Dec 31, 2021 4.82 Mn
Dec 31, 2020 173,172.00
Jun 30, 2010 78,319.00
Mar 31, 2010 0.00